Issues relevant to the adoption and modification of hospital infection-control recommendations for avian influenza (H5N1 infection) in developing countries

Clinical Infectious Diseases

Volumn 45, Issue 10, 2007, Pages 1338-1342

  Apisarnthanarak, Anucha ^a   Warren, David K ^b   Fraser, Victoria J ^b  

^a THAMMASAT UNIVERSITY   (Thailand)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; AVIAN INFLUENZA VACCINE; OSELTAMIVIR; ZANAMIVIR;

AVIAN INFLUENZA; CLINICAL FEATURE; CLINICAL PRACTICE; DEVELOPING COUNTRY; HEALTH CARE ACCESS; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HOSPITAL INFECTION; HOSPITAL MANAGEMENT; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION CONTROL; INFLUENZA VIRUS A H5N1; MEDICAL SPECIALIST; PANDEMIC; PRIORITY JOURNAL; PROPHYLAXIS; SHORT SURVEY; VIRUS TRANSMISSION; ANIMAL; ARTICLE; DISEASE TRANSMISSION; EPIDEMIC; HEALTH CARE POLICY; HOSPITAL; INFLUENZA; METHODOLOGY; POLICY; VIROLOGY;

ANIMALS; DEVELOPING COUNTRIES; DISEASE OUTBREAKS; HEALTH POLICY; HOSPITALS; HUMANS; INFECTION CONTROL; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; ORGANIZATIONAL POLICY;

EID: 36048990144     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/522538     Document Type: Short Survey

References (55)

1. Kilbourne ED. Inluneza pandemics of the 20th century. Emerg Infect Dis 2006; 12:9-14.
2. Meltzer MI, Cox NJ, Fukuda K. The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg Infect Dis 1999; 5:659-71.
3. Meltzer MI. Presentation at the WHO consultation on priority public health interventions before and during the influenza pandemic, Geneva, 16-18 March 2004. Available at: http://www.who.int/csr/disease/avian_influenza/ consultation/en/. Accessed 4 July 2007.
4. Abbott A, Pearson H. Fear of human pandemic grows as bird flu sweeps through Asia. Nature 2004; 427:472-3.
5. Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, et al. Human disease from influenza A (H5N1), Thailand, 2004. Emerg Infect Dis 2005; 11:201-9.
6. Tran TH, Nguyen TL, Nguyen TD, et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 2004; 350:1179-88.
7. Apisarnthanarak A, Kitphati R, Thongphubeth K, et al. Atypical avian influenza (H5N1). Emerg Infect Dis 2004; 10:1321-4.
8. Ungchusak K, Auewarakul P, Dowell SF, et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 2005; 352:333-40.
9. Cox NJ, Tamblyn SE, Tam T. Influenza pandemic planning. Vaccine 2003; 21:1801-3.
10. World Health Organization. WHO global influenza preparedness plan. Available at: http://www.who.int.libproxy.lib.unc.edu/csr/resources/ publications/influenza/GIP_2005_5Eweb.pdf. Accessed 2 May 2007.
11. Beigel JH, Farrar J, Han AM, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005; 353:1374-85.
12. Mounts AW, Kwong H, Izurieta HS, et al. Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. J Infect Dis 1999; 180:505-8.
13. Bridges CB, Lim W, Hu-Primmer J, et al. Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998. J Infect Dis 2002; 185:1005-10.
14. Keawcharoen J, Oraveerakul K, Kuiken T, et al. Avian influenza H5N1 in tigers and leopards. Emerg Infect Dis 2004; 10:2189-91.
15. Thanawongnuwech R, Amonsin A, Tantilertcharoen R, et al. Probable tiger-to-tiger transmission of avian influenza H5N1. Emerg Infect Dis 2005; 11:699-701.
16. Kuiken T, Rimmelzwaan G, van Riel D, et al. Avian H5N1 influenza in cats. Science 2004; 306:241.
17. Katz JM, Lim W, Bridges CB, et al. Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J Infect Dis 1999; 180:1763-80.
18. Buxton Bridges C, Katz JM, Seto WH, et al. Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. J Infect Dis 2000; 181:344-8.
19. Liem NT, Lim W. World Health Organization International Avian Influenza Investigation Team, Vietnam. Lack of H5N1 avian influenza transmission to hospital employees, Hanoi, 2004. Emerg Infect Dis 2005; 11:210-5.
20. Schultsz C, Dong VC, Chau NV, et al. Avian influenza H5N1 and healthcare workers. Emerg Infect Dis 2005; 11:1158-9.
21. Apisarnthanarak A, Erb S, Stephenson I, et al. Seroprevalence of anti-H5 antibody among Thai health care workers after exposure to Avian influenza (H5N1) in a tertiary care center. Clin Infect Dis 2005; 40:e16-8.
22. Kandun IN, Wibisono H, Sedyaningsih ER, et al. Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med 2006; 355:2186-94.
23. Coffey CC, Lawrence RB, Campbell DL, Zhuang Z, Calvert CA, Jensen PA. Fitting characteristics of eighteen N95 filtering-face-piece respirators. J Occup Environ Hyg 2004; 1:262-71.
24. Lim C, Seet RC, Lee KH, Wilder-Smith EP, Chuah BY, Ong BK. Headaches and the N95 face-mask amongst healthcare workers. Acta Neurol Scand 2006; 113:199-202.
25. Li Y, Tokura H, Guo YP, et al. Effects of wearing N95 and surgical facemasks on heart rate, thermal stress and subjective sensations. Int Arch Occup Environ Health 2005; 78:501-9.
26. Kao TW, Huang KC, Huang YL, Tsai TJ, Hsieh BS, Wu MS. The physiological impact of wearing an N95 mask during hemodialysis as a precaution against SARS in patients with end-stage renal disease. J Formos Med Assoc 2004; 103:624-8.
27. Tuabenberger JK, Reid AH, Fanning TG. Capturing a killer flu virus. Sci Am 2005; 292:48-57.
28. Salgado CD, Farr BM, Hall KK, Hayden FG. Influenza in the acute hospital setting. Lancet Infect Dis 2002; 2:145-55.
29. Cinti S, Chenoweth C, Monto AS. Preparing for pandemic influenza: should hospitals stockpile oseltamivir? Infect Control Hosp Epidemiol 2005; 26:852-4.
30. World Health Organization (WHO). WHO guidelines on the use of vaccines and antivirals during influenza pandemics: global health security - epidemic alert and response. Geneva, Switzerland: WHO, 2004:1-11.
31. Ward P, Small I, Smith J, Suter P, Dutkowski R. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother 2005; 55(Suppl 1):i5-21.
32. Brady MT, Sears SD, Pacini DL, et al. Safety and prophylactic efficacy of low-dose rimantadine in adults during an influenza A epidemic. Antimicrob Agents Chemother 1990; 34:1633-6.
33. Shilling M, Povinelli L, Krause P. Efficacy of zanamivir for chemoprophylaxis of nursing home influenza outbreaks. Vaccine 1998; 16:1771-4.
34. Hayden FG, Atmar RL, Schilling M, et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 1999; 341:1336-43.
35. Bowles SK, Lee W, Simor AE, et al. Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999-2000. J Am Geriatr Soc 2002; 50:608-16.
36. Longini IM Jr, Halloran ME, Nizam A, Yang Y. Containing pandemic influenza with antiviral agents. Am J Epidemiol 2004; 159:623-33.
37. Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 2003; 163:1667-72.
38. Whitley RJ, Hayden FG, Reisinger KS, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 2001; 20:127-33.
39. Apisarnthanarak A, Mundy LM. Infection control for emerging infectious diseases in developing countries and resource-limited settings. Infect Control Hosp Epidemiol 2006; 27:885-7.
40. Tambyah PA, Singh KS, Kabib AG. SARS: understanding the coronavirus: accuracy of WHO criteria was similar in a "non-SARS" hospital in Singapore. BMJ 2003; 327:620.
41. Ooi SB, Tambyah PA. Transmission of severe acute respiratory syndrome in an emergency department. Am J Med 2004; 116:486-9.
42. Tsang KW, Ho PL, Ooi GC, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348:1977-85.
43. Ho PL, Tang XP, Seto WH. SARS: hospital infection control and admission strategies. Respirology 2003; 8(Suppl):S41-5.
44. Apisarnthanarak A, Puthavathana P, Kitphati R, et al. Avian influenza H5N1 screening of intensive care unit patients with community-acquired pneumonia. Emerg Infect Dis 2006; 12:1766-9.
45. Olsen SJ, Ungchusak K, Birmingham M, Bresee J, Dowell SF, Chunsuttiwat S. Surveillance for avian influenza in human beings in Thailand. Lancet Infect Dis 2006; 6:757-8.
46. Centers for Disease Control and Prevention. Severe acute respiratory syndrome-Singapore 2003. MMWR Morb Mortal Wkly Rep 2003; 52:405-11.
47. Ho KY, Singh KS, Habib AG, et al. Mild illness associated with severe acute respiratory syndrome coronavirus infection: lessons from a prospective seroepidemiologic study of healthcare workers in a teaching hospital in Singapore. J Infect Dis 2004; 189:642-7.
48. Fisher DA, Lim TK, Lim YT, Singh KS, Tambyah PA. Atypical presentation of SARS. Lancet 2003; 361:1740.
49. Oner AF, Bay A, Arslan S, et al. Avian influenza A (H5N1) infection in eastern Turkey in 2006. N Engl J Med 2006; 355:2179-85.
50. Apisarnthanarak A, Kitphati R, Mundy LM. Difficulty in the rapid diagnosis of avian influenza A infection: Thailand experience. Clin Infect Dis 2007; 44:1252-3.
51. Scheckler WE, Brimhall D, Buck AS, et al. Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol 1998; 19:194-24.
52. Horan-Murphy E, Barnard B, Chenoweth C, et al. APIC/CHICA-Canada infection control and epidemiology: professional and practice standards. Association for Professionals in Infection Control and Epidemiology and the Community and Hospital Infection Control Association-Canada. Am J Infect Control 1999; 27:47-51.
53. Fung CP, Hsieh TL, Tan KH, et al. Rapid creation of a temporary isolation ward for patients with severe acute respiratory syndrome in Taiwan. Infect Control Hosp Epidemiol 2004; 25:1026-32.
54. Yap FH, Gomersall CD, Fung KS, et al. Increase in methicillin-resistant Staphylococcus aureus acquisition rate and change in pathogen pattern associated with an outbreak of severe acute respiratory syndrome. Clin Infect Dis 2004; 39:511-6.
55. Chai LY, Ng TM, Habib AG, Singh K, Kumarasinghe G, Tambyah PA. Paradoxical increase in methicillin-resistant Staphylococcus aureus acquisition rates despite barrier precautions and increased hand washing compliance during an outbreak of severe acute respiratory syndrome. Clin Infect Dis 2005; 40:632-3.